Prevalence of infective endocarditis in patients with systemic lupus erythematosus

Journal of the American Dental Association

Volumn 130, Issue 3, 1999, Pages 387-392

  Miller, Craig S ^a   Egan, Rita M ^a   Falace, Donald A ^a   Rayens, Mary Kay ^b   Moore, Charles R ^c  

^a UNIVERSITY OF KENTUCKY COLLEGE OF DENTISTRY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c LEXINGTON CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; AUTOIMMUNE DISEASE; BACTERIAL ENDOCARDITIS; CLINICAL TRIAL; DENTAL CARE; FEMALE; HEART MURMUR; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTIC PROPHYLAXIS; AUTOIMMUNE DISEASES; DENTAL CARE FOR CHRONICALLY ILL; ENDOCARDITIS, BACTERIAL; FEMALE; HEART MURMURS; HUMANS; KENTUCKY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0033094773     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.1999.0209     Document Type: Article

References (55)

1. Perloth MG. Connective tissue disease and the heart. JAMA 1975;231:410-2.
2. Lehman TJA, Palmeri ST, Hastings C, Klippel JH, Plotz PH. Bacterial endocarditis complicating systemic lupus erythematosus. J Rheumatol 1983;10:655-8.
3. Nihoyannopoulos P, Gomez PM, Joshi J, Loizou S, Walport MJ, Oakley CM. Cardiac abnormalities in systemic lupus erythematosus. Circulation 1990;82:369-75.
4. Metz D, Jolly D, Graciet-Richard J, Nazeyrollas P. Prevalence of valvular involvement in systemic lupus erythematosus and association with antiphospholipid syndrome: a matched echocardiographic study. Cardiology 1994;85:129-36.
5. Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med 1923;33:701-37.
6. Shearn MA. The heart in systemic lupus erythematosus: a review. Am Heart J 1959;58:452-66.
7. Bridgen W, Bywaters EG, Lessof MH, Ross IP. The heart in systemic lupus erythematosus. Br Heart J 1960;22:1-16.
8. Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 1996;335:1424-30.
9. Galve E, Candell-Riera J, Pigrau C, Permanyer-Miralda G, Garcia-Del-Castillo H, Soler-Soler J. Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus. N Engl J Med 1988;319:817-23.
10. Gleason CB, Stoddard MF, Wagner SG, Lingaker RA, Pierangeli S, Harris EN. A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosus. Am Heart J 1993;125:1123-9.
11. Kong TQ, Kellum RE, Haserick JR. Clinical diagnosis of cardiac involvement in systemic lupus erythematosus: a correlation of clinical and autopsy findings in thirty patients. Circulation 1962;26:7-11.
12. Bulkley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy: a study of 36 necropsy patients. Am J Med 1975;58:243-64.
13. Ansari A, Larson PH, Bates HD. Cardiovascular manifestations of systemic lupus erythematosus: current perspective. Prog Cardiovasc Dis 1985;27:421-34.
14. Mandell BF. Cardiovascular involvement in systemic lupus erythematosus. Semin Arthritis Rheum 1987;17:126-41.
15. Klinkhoff AV, Thompson CR, Reid GD, Tomlinson CW. M-mode and two-dimensional echocardiographic abnormalities in systemic lupus erythematosus. JAMA 1985;253:3273-7.
16. Straaton KV, Chatham WW, Reveille JD, Koopman WJ, Smith SH. Clinically significant valvular heart disease in systemic lupus erythematosus. Am J Med 1988;85:645-50.
17. Chartash EK, Lans DM, Paget SA, Qamar T, Lockshin MD. Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Med 1989;86:407-12.
18. Cervera R, Font J, Pare C, et al. Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheum Dis 1992;51:156-9.
19. Sturfelt G, Eskilsson J, Nived O, Truedsson L, Valind S. Cardiovascular disease in systemic lupus erythematosus: a study of 75 patients from a defined population. Medicine 1992;71:216-23.
20. Ford PM, Ford SE, Lillicrap DP. Association of lupus anticoagulant with severe valvular heart disease in systemic lupus erythematosus. J Rheumatol 1988;15:597-600.
21. Khamashta MA, Cervera R, Asherson RA, et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990;335:411-9.
22. Ziporen L, Goldberg I, Arad M, et al. Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves. Lupus 1996;5(3):196-205.
23. Leung WH, Wong KL, Lau CP, Wong CK, Liu HW. Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am J Med 1990;89:411-9.
24. Dubois EL, ed. Lupus erythematosus: a review of the current status of discoid and systemic lupus erythematosus and their variants. 2nd ed. Los Angeles: University of Southern California Press; 1974:26, 27, 274.
25. Zysset MK, Montgomery MT, Redding SW, Dell'Italia LJ. Systemic lupus erythematosus: a consideration for antimicrobial prophylaxis. Oral Surg Oral Med Oral Pathol 1987;64:30-4.
26. De Rossi SS, Glick M. Lupus erythematosus: considerations for dentistry. JADA 1998;129:330-9.
27. Luce EB, Montgomery MT, Redding SW. The prevalence of cardiac valvular pathosis in patients with systemic lupus erythematosus. Oral Surg Oral Med Oral Pathol 1990;70:590-2.
28. Ong ML, Veerapen K, Chambers JB, Lim MN, Manivasagar M, Wang F. Cardiac abnormalities in systemic lupus erythematosus: prevalence and relationship to disease activity. Int J Cardiol 1992;34:69-74.
29. Staples PJ, Gerding DN, Decker JL, Gordon RS Jr. Incidence of infection in systemic lupus erythematosus. Arthritis Rheum 1974;17:1-10.
30. Dzau VJ, Schur PH, Weinstein L. Vibrio fetus endocarditis in a patient with systemic lupus erythematosus. Am J Med Sci 1976;272:331-4.
31. Tornos MP, Galve E, Pahissa A. Clinical considerations regarding infective Libman-Sacks endocarditis. Int J Cardiol 1985;7:409-12.
32. Demircin M, Dogan R, Peker O, Unal S, Pasaoglu I. Aortic insufficiency and enterococcal endocarditis complicating systemic lupus erythematosus. Thorac Cardiovasc Surg 1995;43:302-4.
33. Morin AM, Boyer AS, Nataf P, Gandjbakhch I. Mitral insufficiency caused by systemic lupus erythematosus requiring valve replacement: three case reports and a review of the literature. Thorac Cardiovasc Surg 1996;44:313-6.
34. Christmas B, Ericson B, Hodges T, et al. eds. International classification of diseases, 9th revision, clinical modification. 5th ed. Salt Lake City: Medicode Publications; 1995:206.
35. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
36. Meyer O, Golstein M, Nicaise P, Labarre C, Kahn MF. Heart valve disease in systemic lupus erythematosus. Clin Rev Allergy Immunol 1995;13:49-56.
37. Giunta A, Picillo U, Maione S, et al. Spectrum of cardiac involvement in systemic lupus erythematosus: echocardiographic, echo-Doppler observations and immunological investigation. Acta Cardiol 1993;48:183-97.
38. Gabrielli F, Alcini E, Di Prima MA, Mazzacurati G, Masala C. Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies. Int J Cardiol 1995;51:117-26.
39. Luce EB, Presti CF, Montemayor I, Crawford MH. Detecting cardiac valvular pathology in patients with systemic lupus erythematosus. Spec Care Dentist 1992;12:193-7.
40. Doherty NE, Siegel RJ. Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 1985;110:1257-65.
41. Tikly M, Diese M, Zannettou N, Essop R. Gonococcal endocarditis in a patient with systemic lupus erythematosus. Br J Rheumatol 1997;36:270-2.
42. Schur PH, ed. The clinical management of systemic lupus erythematosus. New York: Grune & Stratton; 1983:9-45.
43. Harvey AM, Shulman LE, Tumulty PA, Conley CL, Shoenrich EH. Systemic lupus erythematosus: a review of the literature and clinical analysis of 138 cases. Medicine 1954;33:291-437.
44. Jessar R, Lamont-Havers R, Ragan C. Natural history of lupus erythematosus disseminatus. Ann Intern Med 1953;38:717.
45. Hejtmancik M, Wright J, Quint R, Jennings F. The cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 1964;68:119-30.
46. Ropes MW, ed. Systemic lupus erythematosus. Cambridge, Mass.: Harvard University Press; 1976:53-4.
47. Wilson WR, Danielson GK, Giuliani ER, Geraci JE. Prosthetic valve endocarditis. Mayo Clin Proc 1982;57:155-61.
48. Karchmer AW. Infective endocarditis. In: Braunwald E, ed. Heart disease: A textbook of cardiovascular medicine. 5th ed. Philadelphia: Saunders; 1997:1077-104.
49. Harris SL. Definitions and demographic characteristics. In: Kaye D, ed. Infective endocarditis. 2nd ed. New York: Raven Press; 1992:1-18.
50. Gladman DD, Urowitz MB, Klippel JH. Systemic lupus erythematosus. In: Klippel JH, ed. Primer on the rheumatic diseases. 11th ed. Atlanta: Arthritis Foundation; 1997:246-62.
51. Doyle EF, Spagnulo M, Taranta A, Kuttner AG, Markowitz M. The risk of bacterial endocarditis during antirheumatic prophylaxis. JAMA 1967;201:807-12.
52. Steckelberg JM, Wilson WR. Risk factors for infective endocarditis. Infect Dis Clin North Am 1993;7:9-19.
53. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 1997;277:1794-801.
54. Chiriboga DE, Yarzebski J, Goldberg RJ, et al. A community-wide perspective of gender differences and temporal trends in the use of diagnostic and revascularization procedures for acute myocardial infarction. Am J Cardiol 1993;71:268-73.
55. Shaw LJ, Miller DD, Romeis JC, Kargl D, Younis LT, Chaitman BR. Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease. Ann Intern Med 1994;120:559-66.